Fig. 4.
Fig. 4. Loss of NF-κB DNA binding precedes annexin V binding. (A) For NF-κB DNA binding, NEs prepared from parental ARP-1 transfectants treated with and without Dex (0.1 μmol/L) for the indicated times were examined by EMSA. (B) Parental ARP-1 cells treated as described above were double stained with annexin-V-FITC and propidium iodide and analyzed for annexin-V binding by flow cytometry. Numbers within dot plots represent percentages of cells in early apoptosis (annexin V+/PI−; lower right) and in late apoptosis and necrosis (annexin V+/PI+; upper left). Percentage of apoptotic cells (next to each lower dot plot) represents the fraction of cells undergoing apoptosis with Dex.

Loss of NF-κB DNA binding precedes annexin V binding. (A) For NF-κB DNA binding, NEs prepared from parental ARP-1 transfectants treated with and without Dex (0.1 μmol/L) for the indicated times were examined by EMSA. (B) Parental ARP-1 cells treated as described above were double stained with annexin-V-FITC and propidium iodide and analyzed for annexin-V binding by flow cytometry. Numbers within dot plots represent percentages of cells in early apoptosis (annexin V+/PI; lower right) and in late apoptosis and necrosis (annexin V+/PI+; upper left). Percentage of apoptotic cells (next to each lower dot plot) represents the fraction of cells undergoing apoptosis with Dex.

Close Modal

or Create an Account

Close Modal
Close Modal